e-Drug3D 398 |
TAPENTADOL
|
cas 175591-23-8 |
CLASS NERVOUS SYSTEM |
ROUTE (list) ORAL |
ATC code |
PK parameters F 32 PERCENT Solubility LOGP = 2.87 |
Target TARGET MU OPIOID RECEPTOR |
DrugCentral Mu-type opioid receptor UNIPROT P35372 OPRM1 Sodium-dependent noradrenaline transporter UNIPROT P23975 SLC6A2 |
Download SDF file | 3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]phenol Formula: Calculated chemical properties: MW 221.33 NB_atoms 16 XLogP 3.08 PSA 26.726 NB_HD 1 NB_HA 2 fsp3 0.57 Lipinski(0=no;1=yes) 1 |
FDA NDA 022304 (pdf not found) INN (TAPENTADOL HYDROCHLORIDE) NUCYNTA (COLLEGIUM PHARM INC) APPROVAL= AP YEAR= 2008 NEWMOLECULARENTITY NDA 200533 (pdf not found) INN (TAPENTADOL HYDROCHLORIDE) NUCYNTA ER (COLLEGIUM PHARM INC) APPROVAL= AP YEAR= 2011 NDA 203794 (pdf not found) INN (TAPENTADOL HYDROCHLORIDE) NUCYNTA (COLLEGIUM PHARM INC) APPROVAL= AP YEAR= 2012 DISCONTINUED NDA 204971 (pdf not found) INN (TAPENTADOL) TAPENTADOL (ACTAVIS ELIZABETH) APPROVAL= TA YEAR= 2015 NDA 205057 (pdf not found) INN (TAPENTADOL) TAPENTADOL (ROXANE) APPROVAL= TA YEAR= 2015 NDA 205015 (pdf not found) INN (TAPENTADOL) TAPENTADOL (ALKEM LABS LTD) APPROVAL= TA YEAR= 2016 NDA 206657 (pdf not found) INN (TAPENTADOL HYDROCHLORIDE) TAPENTADOL HYDROCHLORIDE (ACTAVIS LABS UT INC) APPROVAL= TA YEAR= 2016 NDA 204972 (pdf not found) INN (TAPENTADOL) TAPENTADOL (ACTAVIS ELIZABETH) APPROVAL= TA YEAR= 2017 NDA 206418 (pdf not found) INN (TAPENTADOL) TAPENTADOL (WEST-WARD PHARMS INT) APPROVAL= TA YEAR= 2017 NDA 209369 (pdf not found) INN (TAPENTADOL HYDROCHLORIDE) TAPENTADOL HYDROCHLORIDE (RHODES PHARMS) APPROVAL= TA YEAR= 2017 NDA 214378 (pdf not found) INN (TAPENTADOL HYDROCHLORIDE) TAPENTADOL HYDROCHLORIDE (HUMANWELL PHARMACEUTICAL US INC) APPROVAL= TA YEAR= 2022 |
Other links: |